Adipokines and the Risk of Reflux Esophagitis

Seoul National University

Status: Unknown

Conditions: Visceral Obesity; Reflux Esophagitis

Study type: Observational

Funder types: Other

Identifiers

NCT01560598

gerdadipokine

Details and patient eligibility

About

We aimed to risk faoctors for GERD and association between visceral obesity, plasma adipoline(leptin, adiponectin, IL-6, TNF-α)and development of reflux esophagitis in healthy Koreans.

Enrollment: 600 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• endoscopically proven reflux esophagitis

Exclusion criteria

• those with esophageal hiatal hernia, current PPI medication, upper GI operation history

Trial design

600 participants in 2 patient groups

Reflux esophagitis

Description:

those with endoscopically proven reflux esophagitis

Normal

Description:

those with normal GFS finding (without definite mucosal break at Z-line)